JP2019509270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509270A5 JP2019509270A5 JP2018543324A JP2018543324A JP2019509270A5 JP 2019509270 A5 JP2019509270 A5 JP 2019509270A5 JP 2018543324 A JP2018543324 A JP 2018543324A JP 2018543324 A JP2018543324 A JP 2018543324A JP 2019509270 A5 JP2019509270 A5 JP 2019509270A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- item
- use according
- subject
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021124414A JP2021169528A (ja) | 2016-02-17 | 2021-07-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2023138821A JP2023159405A (ja) | 2016-02-17 | 2023-08-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2024082556A JP2024102370A (ja) | 2016-02-17 | 2024-05-21 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662296563P | 2016-02-17 | 2016-02-17 | |
| US62/296,563 | 2016-02-17 | ||
| US201762453864P | 2017-02-02 | 2017-02-02 | |
| US62/453,864 | 2017-02-02 | ||
| PCT/US2017/018440 WO2017143233A1 (en) | 2016-02-17 | 2017-02-17 | Methods and compositions for cns delivery of arylsulfatase a |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021124414A Division JP2021169528A (ja) | 2016-02-17 | 2021-07-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019509270A JP2019509270A (ja) | 2019-04-04 |
| JP2019509270A5 true JP2019509270A5 (https=) | 2020-03-26 |
Family
ID=58192404
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543324A Pending JP2019509270A (ja) | 2016-02-17 | 2017-02-17 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2021124414A Withdrawn JP2021169528A (ja) | 2016-02-17 | 2021-07-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2023138821A Pending JP2023159405A (ja) | 2016-02-17 | 2023-08-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2024082556A Pending JP2024102370A (ja) | 2016-02-17 | 2024-05-21 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021124414A Withdrawn JP2021169528A (ja) | 2016-02-17 | 2021-07-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2023138821A Pending JP2023159405A (ja) | 2016-02-17 | 2023-08-29 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
| JP2024082556A Pending JP2024102370A (ja) | 2016-02-17 | 2024-05-21 | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11020461B2 (https=) |
| EP (1) | EP3416678A1 (https=) |
| JP (4) | JP2019509270A (https=) |
| CN (2) | CN108883162A (https=) |
| AU (1) | AU2017220100B2 (https=) |
| BR (1) | BR112018016874A2 (https=) |
| CA (1) | CA3014909A1 (https=) |
| MA (1) | MA44237A (https=) |
| MX (2) | MX2018009937A (https=) |
| WO (1) | WO2017143233A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019126376A1 (en) * | 2017-12-19 | 2019-06-27 | Shire Human Genetic Therapies, Inc. | Purified arylsulfatase a and compositons thereof |
| BR112021021908A2 (pt) * | 2019-05-03 | 2022-02-01 | Univ Pennsylvania | Composições úteis no tratamento da leucodistrofia metacromática |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6217552B1 (en) | 1999-03-01 | 2001-04-17 | Coaxia, Inc. | Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma |
| US6537785B1 (en) | 1999-09-14 | 2003-03-25 | Genzyme Glycobiology Research Institute, Inc. | Methods of treating lysosomal storage diseases |
| NZ605874A (en) * | 2010-06-25 | 2015-02-27 | Shire Human Genetic Therapies | Methods and compositions for cns delivery of heparan n-sulfatase |
| SMT201600385T1 (it) * | 2010-06-25 | 2017-03-08 | Shire Human Genetic Therapies | Trasporto di agenti terapeutici all’snc |
| NZ605873A (en) * | 2010-06-25 | 2015-02-27 | Shire Human Genetic Therapies | Methods and compositions for cns delivery of arylsulfatase a |
| CN103179980B (zh) * | 2010-06-25 | 2016-09-28 | 夏尔人类遗传性治疗公司 | 艾杜糖醛酸-2-硫酸酯酶的cns递送的方法和组合物 |
-
2017
- 2017-02-17 EP EP17708395.3A patent/EP3416678A1/en not_active Withdrawn
- 2017-02-17 AU AU2017220100A patent/AU2017220100B2/en active Active
- 2017-02-17 WO PCT/US2017/018440 patent/WO2017143233A1/en not_active Ceased
- 2017-02-17 MX MX2018009937A patent/MX2018009937A/es unknown
- 2017-02-17 JP JP2018543324A patent/JP2019509270A/ja active Pending
- 2017-02-17 US US15/999,472 patent/US11020461B2/en active Active
- 2017-02-17 CA CA3014909A patent/CA3014909A1/en active Pending
- 2017-02-17 BR BR112018016874A patent/BR112018016874A2/pt unknown
- 2017-02-17 MA MA044237A patent/MA44237A/fr unknown
- 2017-02-17 CN CN201780022756.8A patent/CN108883162A/zh active Pending
- 2017-02-17 CN CN202311189440.1A patent/CN117224659A/zh active Pending
-
2018
- 2018-08-16 MX MX2024004034A patent/MX2024004034A/es unknown
-
2021
- 2021-04-30 US US17/246,119 patent/US20210315981A1/en not_active Abandoned
- 2021-07-29 JP JP2021124414A patent/JP2021169528A/ja not_active Withdrawn
-
2023
- 2023-08-29 JP JP2023138821A patent/JP2023159405A/ja active Pending
-
2024
- 2024-05-21 JP JP2024082556A patent/JP2024102370A/ja active Pending
- 2024-09-10 US US18/829,900 patent/US20250099555A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7446322B2 (ja) | アルツハイマー病を治療する方法 | |
| Tang et al. | FGF2 attenuates neural cell death via suppressing autophagy after rat mild traumatic brain injury | |
| Johnson et al. | Myotonic dystrophy: from bench to bedside | |
| Chen et al. | Defective autophagy and mitophagy in Alzheimer’s disease: mechanisms and translational implications | |
| Doan et al. | An update on the basic and clinical science of ketamine analgesia | |
| US20250188158A1 (en) | Treatment of Parkinson's Disease | |
| Rommer et al. | Management of secondary progressive multiple sclerosis: prophylactic treatment—past, present, and future aspects | |
| Gupta et al. | Prolongation of subarachnoid block by intravenous dexmedetomidine for sub umbilical surgical procedures: A prospective control study | |
| EP2808018B1 (en) | Therapeutic agent for diabetes | |
| Ramdas et al. | Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians: S. Ramdas et al. | |
| JP2019509270A5 (https=) | ||
| JP2024102370A (ja) | アリールスルファターゼａのｃｎｓ送達のための方法および組成物 | |
| CN108135880A (zh) | 用于治疗神经退化性疾病的方法及组成物 | |
| FALLON et al. | Biological therapies for obsessive-compulsive disorder | |
| JPWO2015046574A1 (ja) | 虚血後の再灌流に起因する出血を予防するための薬剤 | |
| Kadoi | Selection of anesthetics and muscle relaxants for electroconvulsive therapy | |
| CN106659738B (zh) | 阿尔茨海默病(ad)的治疗和预防 | |
| Dawson et al. | Neurologic complications of commonly used drugs in the hospital setting | |
| AU2018271895A1 (en) | Pharmaceutical combinations of zonisamide and praxipexole, and related methods, for treating synucleinopathies | |
| US12123000B2 (en) | Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity | |
| Sodhi et al. | Convulsions in a critically ill patient on hemodialysis: Possible role of low dose colistin | |
| US20210301006A1 (en) | Methods of treating acute respiratory distress syndrome | |
| Chen et al. | Advances in Studying the Pathologic Mechanisms and Treatment Strategies of Transthyretin Amyloidosis | |
| Robert et al. | Hearing loss during osteosarcoma chemotherapy: when acute ifosfamide toxicity revealed unnoticed methotrexate encephalopathy | |
| Jain | Neuroprotection in Miscellaneous Neurological Disorders |